LENSAR (NASDAQ:LNSR – Get Free Report) and Quipt Home Medical (NASDAQ:QIPT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
Volatility and Risk
LENSAR has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500.
Profitability
This table compares LENSAR and Quipt Home Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LENSAR | -34.03% | -49.02% | -21.12% |
| Quipt Home Medical | -1.95% | -4.51% | -2.01% |
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LENSAR | $48.87 million | 1.83 | -$14.38 million | ($1.46) | -5.27 |
| Quipt Home Medical | $245.92 million | 0.44 | -$2.78 million | ($0.15) | -16.60 |
Quipt Home Medical has higher revenue and earnings than LENSAR. Quipt Home Medical is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
40.2% of LENSAR shares are owned by institutional investors. Comparatively, 42.8% of Quipt Home Medical shares are owned by institutional investors. 38.5% of LENSAR shares are owned by insiders. Comparatively, 4.2% of Quipt Home Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for LENSAR and Quipt Home Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LENSAR | 0 | 0 | 1 | 0 | 3.00 |
| Quipt Home Medical | 1 | 0 | 3 | 2 | 3.00 |
LENSAR presently has a consensus target price of $8.00, suggesting a potential upside of 3.90%. Quipt Home Medical has a consensus target price of $6.25, suggesting a potential upside of 151.00%. Given Quipt Home Medical’s higher possible upside, analysts clearly believe Quipt Home Medical is more favorable than LENSAR.
Summary
Quipt Home Medical beats LENSAR on 10 of the 14 factors compared between the two stocks.
About LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.
